Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2000

View Archived Issues

Atlantic submits IND for CT-3 to FDA; phase I trials to commence in France

Amarillo Biosciences reports phase III results for interferon alfa in Sjogren's syndrome

Celgene awarded patent for drug distribution system

Proof of concept demonstrated for PPL's transgenic BSSL

Clinical hold placed on South African study of Coviracil

Memantine improves cognition in vascular dementia patients

SangCya approved in Germany

Magainin discovers additional aminosterols with therapeutic potential

CV Therapeutics receives milestone from Biogen

Potential new diagnostic for AD presented by Axonyx

Periodontix's histatin mouthrinse reduces plaque and gingivitis

L-Arginine prevents chronic ciclosporin-induced renal dysfunction in heart transplant recipients

Canine studies demonstrate efficacy of NIP-142 in atrial flutter

Deleterious effects reported for ET antagonist immediately following MI in rat model

Japanese investigators explore uses for new chymase inhibitor SUN-C8257

NU-3108: profile of a novel nucleoside transport inhibitor

Small-molecule AICARFT inhibitors in the pipeline at Agouron

New benzodiazepinone derivatives under study at Aventis as inhibitors of bone resorption

Pfizer's new opioid receptor ligands claimed for use in painful, inflammatory and other disorders

Roche describes new ligands for the opioid-like receptor OFQ with a piperidine structure

Novel dihydrobenzopyrans exert both antiarrhythmic and antifibrillatory activities

Potent inhibition of human PDE4 reported for new Kyowa Hakko compound

Antitumor activity and pharmacokinetics of new taxoid TXD-258 discussed at ACS meeting

Aradigm announces gene therapy research collaboration with UCSF

New ocular antibiotic enters the pipeline at InSite Vision

Servier succeeds in improving antitumor activity of acronycine with S-23906-1

AVI-4126, a novel antisense compound; preclinical data presented recently support phase I/II trials

Keppra receives Swiss approval for treatment of epilepsy

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...